The investment firm increased its holdings in the genomics company by 468,463 shares, lifting its position value to $33.62 million.
Prosight Management added 468,463 shares of GeneDx Holdings (NASDAQ:WGS) in a $42.72 million transaction, based on first-quarter average pricing. The move raised the quarter-end value of its position by $26.46 million to $33.62 million.
The new stake represents 5.51% of Prosight’s 13F reportable assets. GeneDx shares closed at $47.31 on Friday, underperforming the S&P 500, which gained 28% over the past year. The company focuses on AI-driven genomic data analytics.
Prosight’s top holdings include NKTR ($52.88 million), JANX ($49.34 million), and PRCT ($48.64 million), with GeneDx now among its largest positions.